For the Inventor, By the Inventor

Enter assignee name

Auckland, New Zealand

Genesis Research & Development Corporation Limited

USPTO Granted Patents = 26

CIPO Patents = 1

Forward Citations = 179

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

James Douglas Watson (7 out of 21 patents)

Ross L Prestidge (6 out of 10 patents)

Alain Delcayre (6 out of 14 patents)

4. Paul L Tan (6 out of 6 patents)

5. Elizabeth Visser (3 out of 7 patents)

6. Matthew Sleeman (3 out of 3 patents)

7. Nevin Abernethy (3 out of 3 patents)

8. Paul L J Tan (3 out of 3 patents)

9. Lorna Strachan (3 out of 3 patents)

10. Jun Hiyama (3 out of 3 patents)

11. Leonard N Bloksberg (2 out of 17 patents)

12. Ilkka Havukkala (2 out of 14 patents)

13. James Greg Murison (2 out of 2 patents)

14. Timothy Strabala (2 out of 2 patents)

15. Nicolaas J Nieuwenhuizen (2 out of 2 patents)

26 patents: Sort by Forward Citations

1. 7192590 - Compounds for treatment of infectious and immune system disorders and methods for their use (2007-03-20),

2. 7083791 - Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides (2006-08-01),

3. 7041295 - Compounds for treatment of infectious and immune system disorders and methods for their use (2006-05-09),

4. 6797271 - Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides (2004-09-28),

5. 6768041 - Compositions isolated from plant cells and their use in the modification of plant cell signaling (2004-07-27),

6. 6723327 - Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae (2004-04-20),

7. 6716430 - Compositions isolated from M. vaccae and their use in the modulation of immune responses (2004-04-06),

8. 6573095 - Polynucleotides isolated from skin cells (2003-06-03),

9. 6436898 - Compounds for treatment of infectious and immune system disorders and methods for their use (2002-08-20),

10. 6410720 - Compounds and methods for treatment and diagnosis of mycobacterial infections (2002-06-25),

11. 6406704 - Compounds and methods for treatment and diagnosis of mycobacterial infections (2002-06-18),

12. 6380362 - Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use (2002-04-30),

13. 6361776 - Compounds isolated from M. vaccae and their use in modulation of immune responses (2002-03-26),

14. 6359198 - Compositions isolated from plant cells and their use in the modification (2002-03-19),

15. 6358734 - Compounds for treatment of infectious and immune system disorders and methods for their use (2002-03-19),

Genesis Research & Development Corporation Limited is a leading research and development company that specializes in a wide range of fields including biotechnology, pharmaceuticals, and healthcare. With a team of dedicated scientists and state-of-the-art facilities, Genesis R&D is committed to advancing scientific knowledge and developing innovative solutions to address global challenges. Visit the website to learn more about their cutting-edge research projects and collaborations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

26 Patents

#13 in Auckland

#26 in New Zealand

#24,104 in the World

Auckland, New Zealand

Genesis Research & Development Corporation Limited

Forward Citations = 179

23 inventors:

James Douglas Watson (7 out of 21 patents)

Ross L Prestidge (6 out of 10 patents)

Alain Delcayre (6 out of 14 patents)

4. Paul L Tan (6 out of 6 patents)

5. Elizabeth Visser (3 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…